TD Waterhouse Canada’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10
Closed -$124 2093
2024
Q4
$124 Hold
10
﹤0.01% 1877
2024
Q3
$109 Hold
10
﹤0.01% 1815
2024
Q2
$71 Buy
+10
New +$76 ﹤0.01% 1847
2024
Q1
Sell
-10
Closed -$83 1973
2023
Q4
$83 Hold
10
﹤0.01% 1661
2023
Q3
$126 Hold
10
﹤0.01% 1655
2023
Q2
$185 Hold
10
﹤0.01% 1687
2023
Q1
$252 Hold
10
﹤0.01% 1676
2022
Q4
$184 Hold
10
﹤0.01% 1650
2022
Q3
$239 Hold
10
﹤0.01% 1654
2022
Q2
$197 Hold
10
﹤0.01% 1697
2022
Q1
$270 Hold
10
﹤0.01% 1731
2021
Q4
$319 Buy
+10
New +$286 ﹤0.01% 1699

Other funds holding CDMO

TD Waterhouse Canada's CDMO Position: Q1 2025 in Review

TD Waterhouse Canada sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 10 shares — an estimated $124 sold.

TD Waterhouse Canada first reported a position in CDMO in Q4 2021 and held it in 12 quarters. The position peaked at $319 in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • TD Waterhouse Canada reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 10 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $124.
  • TD Waterhouse Canada first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
  • TD Waterhouse Canada's Avid Bioservices, Inc. Common Stock position peaked at $319 in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on TD Waterhouse Canada's 13F filing for Q1 2025, filed 9 May 2025.